The 2009 Report on Chiral-Based Products: World Market Segmentation by CityIcon Group International, Inc.January 5, 2009 329 Pages - SKU: ICN2102822 |
| Countries covered: Global This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major city of the world. It then ranks these cities and reports them in terms of their size as a percent of the country where they are located, their geographic region (e.g. Africa, Asia, Europe, Middle East, North America, Latin America), and the total world market. In performing various economic analyses for its clients, I have been occasionally asked to investigate the market potential for various products and services across cities. The purpose of the studies is to understand the density of demand within a country and the extent to which a city might be used as a point of distribution within its region. From an economic perspective, however, a city does not represent a population within rigid geographical boundaries. To an economist or strategic planner, a city represents an area of dominant influence over markets in adjacent areas. This influence varies from one industry to another, but also from one period of time to another. In what follows, I summarize the economic potential for the world's major cities for chiral-based products for the year 2009. The goal of this report is to report my findings on the real economic potential, or what an economist calls the latent demand, represented by a city when defined as an area of dominant influence. The reader needs to realize that latent demand may or may not represent real sales. For many items, latent demand is clearly observable in sales, as in the case for food or housing items. Consider, however, the category satellite launch vehicles . Clearly, there are no launch pads in most cities of the world. However, the core benefit of the vehicles (e.g. telecommunications, etc.) is consumed by residents or industries within the world's cities. Without certain cities, in other words, the market for satellite launch vehicles would be lower for the world in general. One needs to allocate, therefore, a portion of the worldwide economic demand for launch vehicles to both regions and cities. This report takes the broader definition and considers, therefore, a city as a part of the global market. |
More Global Drug Discovery Reports
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by
Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 by
GlobalData
Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012 provides data on the Non-Alcoholic Steatohepatitis ...
Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 by
GlobalData
Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012 provides data on the Tachycardia (Tachyarrhythmias) ...
Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 by
GlobalData
Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, H1, 2012 provides data on the ...
Lung Injury Global Clinical Trials Review, H1, 2012 by
GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury ...
See all reports like this >>
Related Markets
Drug Discovery Reports
- Biosensors - A Global Market Overview
- Nucleic Acid Therapies in Oncology Drug Pipeline Update 2012
- Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)
- Synthetic Biology: Emerging Global Markets
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
